BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2001
View Archived Issues
Potent, selective and orally bioavailable CCR5 antagonist obtained at Schering-Plough
Read More
Additional patient enrollment suspended in phase III study of Aptosyn and Taxotere
Read More
Safer NSAIDs designed by linking ibuprofen to furoxan moieties
Read More
Genentech and Xoma to include additional study in Xanelim BLA submission to FDA
Read More
Folate-based thymidylate synthase inhibitor CW-252053 safe and effective in tumor-bearing mice
Read More
NeoPharm initiates phase I/II clinical trial for LEM in cancer
Read More
Positive results shown in preliminary analysis of phase II PTI-555 trial
Read More
Experimental dog model of osteoarthritis used to evaluate therapeutic effects of ML-3000
Read More
AtheroGenics reacquires rights to AGI-1067 from Schering-Plough
Read More
Pfizer's voriconazole recommended for treatment of acute invasive aspergillosis
Read More
Chondrocyte damage induced by proinflammatory cytokine attenuated by PBN
Read More
Nastech initiates phase I clinical trial of intranasal somatropin
Read More
Etoricoxib improves quality-of-life measures in osteoarthritis patients
Read More
PhotoCure begins phase III Hexvix program for bladder cancer detection
Read More
Airways effects of Y-27632 and procaterol compared in guinea pigs
Read More
Enrollment in phase II LDP-341 multiple myeloma trial completed ahead of schedule
Read More
Recombinant molecule selected for clinical development as mucositis therapy by Alizyme
Read More
L-Arginine has beneficial effects on blood pressure and erectile dysfunction in rat model
Read More
Agonists at PPAR receptors described by Merck for Rx of diabetes, etc.
Read More
Inhibitors of MMP and/or TNF-alpha reported in patent by Fujisawa
Read More
Fujisawa reveals new antiplatelet agents
Read More
Synthesis and use of nAChR receptor ligands described by AstraZeneca
Read More
Aniline thyroid hormone receptor agonists presented by BMS team
Read More
New pyrimidine compounds and use as chemokine receptor modulators
Read More
